These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24604750)

  • 21. Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy.
    Broemme J; Abu-Isa J; Kottke R; Beck J; Wiest R; Malthaner M; Schmidhalter D; Raabe A; Aebersold DM; Pica A
    Strahlenther Onkol; 2013 Sep; 189(9):765-70. PubMed ID: 23934329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
    Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
    Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
    Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
    J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative Stereotactic Radiosurgery Using 5-Gy × 5 Sessions in the Management of Brain Metastases.
    Abuodeh Y; Ahmed KA; Naghavi AO; Venkat PS; Sarangkasiri S; Johnstone PAS; Etame AB; Yu HM
    World Neurosurg; 2016 Jun; 90():58-65. PubMed ID: 26921701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation.
    Eaton BR; Gebhardt B; Prabhu R; Shu HK; Curran WJ; Crocker I
    Radiat Oncol; 2013 Jun; 8():135. PubMed ID: 23759065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of biological effective dose-based fractionated stereotactic radiation therapy for metastatic brain tumors from non-small cell lung cancer.
    Matsuyama T; Kogo K; Oya N
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):984-90. PubMed ID: 23092725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study.
    Murai T; Ogino H; Manabe Y; Iwabuchi M; Okumura T; Matsushita Y; Tsuji Y; Suzuki H; Shibamoto Y
    Clin Oncol (R Coll Radiol); 2014 Mar; 26(3):151-8. PubMed ID: 24332223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma.
    Hauswald H; Stenke A; Debus J; Combs SE
    BMC Cancer; 2015 Jul; 15():537. PubMed ID: 26201853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic fractionated radiotherapy of the resection cavity in patients with one to three brain metastases.
    Bilger A; Milanovic D; Lorenz H; Oehlke O; Urbach H; Schmucker M; Weyerbrock A; Nieder C; Grosu AL
    Clin Neurol Neurosurg; 2016 Mar; 142():81-86. PubMed ID: 26816106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic radiotherapy for large solitary brain metastases.
    Feuvret L; Vinchon S; Martin V; Lamproglou I; Halley A; Calugaru V; Chea M; Valéry CA; Simon JM; Mazeron JJ
    Cancer Radiother; 2014 Mar; 18(2):97-106. PubMed ID: 24439342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionated stereotactic radiotherapy of brain metastases: results of a retrospective study.
    Gruber I; Stark P; Weidner K; Treutwein M; Koelbl O
    Radiat Oncol; 2023 May; 18(1):85. PubMed ID: 37217924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastases.
    Oermann EK; Kress MA; Todd JV; Collins BT; Hoffman R; Chaudhry H; Collins SP; Morris D; Ewend MG
    J Neurosurg; 2013 Nov; 119(5):1131-8. PubMed ID: 24010977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.
    Zeng KL; Sahgal A; Husain ZA; Myrehaug S; Tseng CL; Detsky J; Sarfehnia A; Ruschin M; Campbell M; Foster M; Das S; Lipsman N; Bjarnason GA; Atenafu EG; Maralani PJ; Soliman H
    J Neurooncol; 2021 Mar; 152(1):173-182. PubMed ID: 33453002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
    Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
    Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
    Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.
    Kim DH; Schultheiss TE; Radany EH; Badie B; Pezner RD
    J Neurooncol; 2013 Oct; 115(1):37-43. PubMed ID: 23813230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases.
    Bernard ME; Wegner RE; Reineman K; Heron DE; Kirkwood J; Burton SA; Mintz AH
    J Cancer Res Ther; 2012; 8(2):215-21. PubMed ID: 22842364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluatıon of hypofractıonated stereotactıc radıotherapy (HFSRT) to the resectıon cavıty after surgıcal resectıon of braın metastases: A sıngle center experıence.
    Dincoglan F; Sager O; Uysal B; Demiral S; Gamsiz H; Gündem E; Elcim Y; Dirican B; Beyzadeoglu M
    Indian J Cancer; 2019; 56(3):202-206. PubMed ID: 31389381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
    Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.